REverSe TRanscrIptase chain termination ( RESTRICT ) for selective measurement of nucleotide analogs used in HIV care and prevention is a research paper published in Bioengineering & Translational Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: R01AI136648
National Institute of Allergy and Infectious Diseases
Grant: R01AI157756
National Institute of Allergy and Infectious Diseases
Grant: R21AI127200
National Institute of Biomedical Imaging and Bioengineering
Grant: U54EB027690
National Institutes of Health
Grant: AI027757
NIAID NIH HHS
Grant: K99 AI167063
NIAID NIH HHS
Grant: P30 AI027757
National Institutes of Health
Grant: 3P30AI027757-36S1
University of Washington/Fred Hutch Center for AIDS Research
National Institutes of Health
Grant: 1R01AI157756-01
A novel REverSe Transcriptase Chain Termination (RESTRICT) assay for near-patient, objective monitoring of long-term PrEP adherence
National Institutes of Health
Grant: 1R21AI127200-01
A Point-of-Care Assay to Measure Tenofovir for Monitoring PrEP and ART Adherence
National Institutes of Health
Grant: 3U54EB027690-02S1
Emergency COVID-19 supplement for Atlanta Center for Microsystems Engineered Point-of-Care Technoloites (ACME POCT)
National Institutes of Health
Grant: 5R01AI136648-02
A Rapid Point-of-Care Test to Improve ART and PrEP Adherence
Momental Foundation
M.J. Murdock Charitable Trust
Center for AIDS Research, University of Washington
University of Washington
FWCI
0.77
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals